New pill aims to tame painful lupus skin flares
NCT ID NCT07470970
First seen Mar 19, 2026
Summary
This study is testing whether a pill called enpatoran can safely reduce active skin rashes in people with lupus. About 202 participants with moderate-to-severe lupus skin symptoms will take either enpatoran or a placebo pill for 24 weeks, while continuing their standard lupus medications. The main goal is to see if the drug can significantly clear skin lesions and reduce symptoms like redness, scaling, and itch.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Darmstadt, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Continued anifrolumab treatment studied for lupus and related diseases
- Scientists probe hidden clot risks in autoimmune skin disorders
- Psoriasis cream could tame lupus skin flares
- New lupus drug candidate begins first safety tests in humans
- New pill could ease lupus skin rashes in major trial
- 1,000 lupus patients join hunt for skin disease genes